Thijs Gerritzen

Company: Amarna Therapeutics B.V.
Job title: Principal Scientist Process Development
Seminars:
Exploring Alternative Viral Vector Methods for Delivering Gene Therapies 3:45 pm
An overview of the immunogenicity issues surrounding AAV vectors and some different approaches to overcome this How to overcome immune barriers to gene therapy delivery via a novel viral vector method Discussing some of the regulatory challenges unique to developing novel viral vectorsRead more
day: Day Two